Liminatus Pharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CYGNUS CAPITAL ADVISORS, LLC | 09/03/2026 | 329.33 K | $36.00 K | -5.90% | 1.39% |
| XTX TOPCO LTD | 08/14/2026 | 221.84 K | $24.49 K | 100.00% | 0.93% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 138.42 K | $15.28 K | 17.52% | 0.58% |
| CITADEL ADVISORS LLC | 09/02/2026 | 56.09 K | $6.19 K | -91.72% | 0.24% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 50.44 K | $5.55 K | 0.00% | 0.21% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 40.22 K | $4.44 K | 100.00% | 0.17% |
| STONEX GROUP INC. | 08/12/2026 | 26.06 K | $3.93 K | 100.00% | 0.11% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 22.98 K | $2.53 K | 0.00% | 0.10% |
| STATE STREET CORP | 08/07/2026 | 19.00 K | $2.10 K | 0.00% | 0.08% |
| UBS GROUP AG | 08/13/2026 | 16.73 K | $1.84 K | -69.35% | 0.07% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 08/11/2026 | 13.15 K | $1.45 K | -62.12% | 0.06% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 7.09 K | $783 | -6.26% | 0.03% |
| BARCLAYS PLC | 08/14/2026 | 4.29 K | $474 | 100.00% | 0.02% |
| BLACKROCK, INC. | 08/07/2026 | 313 | $35 | -97.64% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 07/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Liminatus Pharma Inc. institutional Ownership - FAQ's
During the previous two years, 20 institutional investors and hedge funds held shares of Liminatus Pharma Inc.. The most heavily invested institutionals were:
Cygnus Capital Advisors, LLC: 329,333
XTX Topco Ltd: 221,839
GEODE CAPITAL MANAGEMENT, LLC: 138,418
CITADEL ADVISORS LLC: 56,089
VANGUARD CAPITAL MANAGEMENT LLC: 50,440
GOLDMAN SACHS GROUP INC: 40,220
3.98% of Liminatus Pharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.02 M shares in the last 24 months. This purchase volume represents approximately $234.46 K in transactions.